Blau syndrome

QJM: An International Journal of Medicine

Volumn 104, Issue 11, 2011, Pages 997-998

  Martin, J ^a   Kodjikian, L ^a   Duquesne, A ^b   Le scanff, J ^b   Seve P ^b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GOLD SALT; METHOTREXATE; MYDRIATIC AGENT; PREDNISONE;

ADULT; BLAU SYNDROME; CAMPTODACTYLY; CASE REPORT; CATARACT; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; MALE; NOTE; PHACOEMULSIFICATION; PRIORITY JOURNAL; UVEITIS; VISUAL ACUITY;

EID: 84155179283     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq188     Document Type: Note

References (5)

1. Arostegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, et al. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 2007; 56:3805-13.
2. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr 1985; 107:689-93.
3. Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003; 110:2040-4.
4. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29:19-20.
5. Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, De Marchi M, et al. Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev 2009; 8:228-32.